Viewing StudyNCT00436800



Ignite Creation Date: 2024-05-05 @ 5:21 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00436800
Status: COMPLETED
Last Update Posted: 2009-09-18
First Post: 2007-02-16

Brief Title: Gemcitabine and Oxaliplatin GEMOX in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma
Sponsor: Sanofi
Organization: Sanofi

Organization Data

Organization: Sanofi
Class: INDUSTRY
Study ID: L_9281
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Sanofi
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Medical Affairs Study Director
Old Organization: sanofi-aventis

Collaborators